Public Profile
close
Affiliations
UCLA School of Medicine, Los Angeles, CA
DisclosureDr. Ansell has received consulting fees from Genentech and honoraria related to service on an advisory board from Pfizer Inc. Dr. Ansell has ownership interest in Bruin Pharmaceuticals and Amgen.
| Program Name | Last Air Date | Hosts/Guests |
|---|---|---|
| Emerging HDL Therapies: What’s Next on the Clinical Research Horizon | 03/29/2025 |
